Effect of MDR1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype

被引：0
|
作者：
Vanhove, Thomas [1 ]
Annaert, Pieter [2 ]
Kuypers, Dirk R. J. [1 ]
机构：
[1] Univ Hosp Leuven, Nephrol & Renal Transplantat, Leuven, Belgium
[2] Univ Leuven, KU Leuven, Pharmaceut & Pharmacol Sci, Leuven, Belgium
来源：
TRANSPLANTATION | 2016年 / 100卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
420.13
引用
收藏
页码：S167 / S168
页数：2
相关论文
共 50 条
  • [21] Tacrolimus, but not cyclosporine, dose requirement is correlated with CYP3A5*3 and CYP3A4*1B genotype
    Hesselink, DA
    van Schaik, RHN
    Gregoor, PJHS
    Weimar, W
    van Gelder, T
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (03) : 359 - 359
  • [22] Tacrolimus, but not cyclosporine, dose requirement is correlated with CYP3A5*3 and CYP3A4*1B genotype
    Hesselink, DA
    van Schaik, RHN
    Gregoor, PJHS
    Weimar, W
    van Gelder, T
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 514 - 514
  • [23] Effect of CYP3A5, CYP3A4 and ABCB1 polymorphisms on tacrolimus exposure in renal transplantation patients
    Ajmi, M.
    Sahtout, W.
    Omezzine, A.
    Amor, D.
    Abderahmene, A.
    Azzabi, A.
    Ben-Rejeb, N.
    Achour, A.
    Bouslama, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 89 - 89
  • [24] Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients
    Cusinato, Diego Alberto C.
    Lacchini, Riccardo
    Romao, Elen A.
    Moyses-Neto, Miguel
    Coelho, Eduardo B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (02) : 364 - 372
  • [25] Response to "CYP3A5 Genotype, but Not CYP3A4*1b, CYP3A4*22, or Hematocrit, Predicts Tacrolimus Dose Requirements in Brazilian Renal Transplant Patients"
    de Jonge, H.
    Kuypers, D. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (02) : 202 - 203
  • [26] Impact of CYP3A5 and MDR1 polymorphisms on tacrolimus and sirolimus kinetics of kidney transplant recipients
    Frisman, M
    Renders, L
    Haenisch, S
    Mosyagin, I
    Cascorbi, I
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 705 - 706
  • [27] THE INFLUENCE OF CYP3A4 AND CYP3A5 GENOTYPE AND PHENOTYPE ON THE PHARMACOKINETICS OF TACROLIMUS IN HEALTHY CHINESE.
    Jiao, Z.
    Shi, X.
    Geng, F.
    Cui, X.
    Qiu, X.
    Zhong, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S52 - S52
  • [28] Melding Pharmacogenomic Effect of MDR1 and CYP3A5 Gene Polymorphism on Tacrolimus Dosing in Renal Transplant Recipients in Northern India
    Prasad, Narayan
    Jaiswal, Akhilesh
    Behera, Manas Ranjan
    Agarwal, Vikas
    Kushwaha, Ravi
    Bhadauria, Dharmendra
    Kaul, Anupama
    Gupta, Amit
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (01): : 28 - 38
  • [29] Influence of CYP3A5 and MDR1(ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Chinese Renal Transplant Recipients
    Rong, G.
    Jing, L.
    Deng-Qing, L.
    Hong-Shan, Z.
    Shai-Hong, Z.
    Xin-Min, N.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3455 - 3458
  • [30] The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients
    Yates, CR
    Zhang, WH
    Song, PF
    Li, S
    Gaber, AO
    Kotb, M
    Honaker, MR
    Alloway, RR
    Meibohm, B
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (06): : 555 - 564
12345